NYCTrainKUHR

@nyctrainkuhr.bsky.social

NY Consortium for Interdisciplinary TRAINing in Kidney, Urological & Hematological Research (KUHR) @einsteinmededu.bsky.social | Icahn School of Medicine at Mount Sinai | @stonybrooku.bsky.social | @columbiamed.bsky.social Website: https://nyckuhr.org/

On behalf of the Editorial Board of Experimental Hematology, we can’t share enough how excited we are about our new article types—Standards in Hematology and ExpHem Insights. A real chance to highlight best practices and key research—there’s no other venue in the field. Major relaunch!

ISEH - International Society for Experimental Hematology@isehsociety.bsky.social · last wk.

📢 Experimental Hematology, the official journal of ISEH, has launched new article types and author incentives! View the latest updates and submit your next manuscript: iseh.org/Publications...

Congratulations to our own postdoctoral fellow trainee, Dr. Jonathan Haydak, on receiving the 2026 NYC Partnership Pilot Projects Grant to support community screening and education for Cardiovascular–Kidney–Metabolic (CKM) syndrome! Well deserved!

Bild

Thrilled to share that our latest review—led by @aysegulerdemm.bsky.social—synthesizing insights into complex intrinsic and extrinsic metabolic regulation of HSC fate and its implications for leukemogenesis, is published in March 2026 issue of @natcellbio.nature.com. @nickvangastel.bsky.social

Bild
Nature Cell Biology@natcellbio.nature.com · 5mo ago

👋Our March issue is out! Cover: #Adipose#tumor in #immune escape 👉Reviews on: #metabolism #hematopoiesis ; #amnion ; #brain #lipids 🔬 #mitochondria #LipidDroplets #aging #autophagy #mechanobiology #neurodegeneration #ferroptosis #chromatin #metastasis & more! www.nature.com/ncb/volumes/...

An executive program member, Dr. Ito (@keisukeito-lab.bsky.social, @einsteinmededu.bsky.social), has been elected an Active Member of the American Society for Clinical Investigation (ASCI), recognizing physician-scientists under 50 for major contributions to medical research. Huge congrats, Keisuke!

Keisuke Ito@keisukeito-lab.bsky.social · 5mo ago

Extremely honored to be elected to ASCI (@the-asci.org) member!! Deeply grateful to my current and former lab members, collaborators, colleagues, and mentors—this milestone would not have been possible without you. Proud to work with such an incredible team! montefioreeinstein.org/news/2026/03...

Thank you so much, Vijay (@bloodgenes.bsky.social), for highlighting our study led by Trieu, @tewhey.bsky.social, and Satish Nandakumar on the mechanistic link by which noncoding genetic variants drive the selective advantage of mutant CHIP clones! @einsteinmededu.bsky.social

Vijay G. Sankaran@bloodgenes.bsky.social · 6mo ago

Check out this fascinating MPRA in human hematopoietic cells from Satish Nandakumar, @tewhey.bsky.social, and team!! www.biorxiv.org/content/10.6...

Honored to contribute to this true team effort led by Drs. Samar Chakraborty and Aditi Shastri @einsteinmededu.bsky.social, including MECCC and NYU, translationally examining the clinical target in VEN-resistant AML with a STAT3 degrader to correct mitochondrial dysregulation. go.nature.com/4awWJmx

Bild
STEMCELL Science News@stemcellsciencenews.com · 6mo ago

Dr. Aditi Shastri and team at the Montefiore Einstein Comprehensive Cancer Center reveal that a STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. 🔖 https://go.nature.com/4awWJmx